Brief: Strides Pharma Science Says FDA Inspection Of Singapore Facility Completed With Zero Observations
08/08/2022 15:24
Aug 8 (Reuters) - Strides Pharma Science Ltd SRID.NS :
* ANNOUNCES SUCCESSFUL COMPLETION OF US FDA INSPECTION AT
ITS
SINGAPORE FACILITY
* INSPECTION WAS COMPLETED SUCCESSFULLY WITH ZERO 483
OBSERVATIONS
Further company coverage: SRID.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees